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In Brief
Parker et al. find that thalamostriatal synapses are a site of maladaptive changes in PD mice. After dopamine depletion, the relative strength of thalamic drive to the two basal ganglia output pathways was reversed, biasing drive away from the ''Go'' pathway. Chemogenetic or optogenetic inhibition of thalamic inputs to striatum restored motor function.
INTRODUCTION
The underlying pathophysiology of Parkinson's disease (PD) remains poorly understood despite decades of research. The pathological hallmark of PD is a progressive loss of dopamine neurons in the substantia nigra pars compacta, which extensively innervates the dorsal striatum (Ehringer and Hornykiewicz, 1960) . Loss of striatal dopamine is proposed to increase efficacy of the indirect pathway basal ganglia circuit (thought to normally suppress movement) and/or decrease efficacy of the direct pathway circuit (thought to normally facilitate movement) (Albin et al., 1989; DeLong, 1990) . A number of studies revealed PD-associated intrinsic and synaptic changes in direct and indirect pathway striatal medium spiny neurons (dMSNs and iMSNs) (Day et al., 2006; Fieblinger et al., 2014; Suá rez et al., 2014) , but little is known about changes to striatal inputs arising from distinct brain regions, which may be differentially affected in PD.
MSNs require significant excitatory synaptic drive to spike (Wickens and Wilson, 1998) , which they receive primarily from the cortex and thalamus (Kemp and Powell, 1971) . Corticostriatal afferents have received the most attention in PD research, and dysregulation of synaptic plasticity at these inputs is thought to contribute to imbalanced basal ganglia circuit function (Kreitzer and Malenka, 2008; Surmeier et al., 2009 ). In contrast, fewer studies have examined the thalamostriatal system in PD (Smith et al., 2014) . Here, we find that the relative strength of thalamic inputs to dMSNs and iMSNs is reversed after dopamine depletion, biasing excitatory drive to the indirect pathway. Consistent with this observation, chemogenetic and optogenetic inhibition of thalamostriatal terminals markedly improved parkinsonian motor deficits.
RESULTS

Reduced Thalamostriatal Drive to dMSNs in Parkinsonian Animals
To assay the relative excitatory input strength onto dMSNs versus iMSNs, we performed simultaneous voltage-clamp recordings from identified d/iMSN pairs in slices containing the dorsolateral striatum (DLS) from mice expressing Cre-dependent ChR2-EYFP in thalamostriatal (VGLUT2-Cre) or corticostriatal (Emx1-Cre) projections. 1 to 2 weeks before recordings, 6-hydroxydopamine (6OHDA) or saline was injected into the left medial forebrain bundle to produce parkinsonian or control animals, respectively ( Figure 1D ). In VGLUT2-Cre animals, strong EYFP expression was centered in Pf ( Figure 1A) , and dense axonal expression was observed in the DLS ( Figure 1B ). Brief light pulses through the microscope objective ( Figure 1E ) elicited fast excitatory postsynaptic currents (EPSCs) in both MSN subtypes ( Figure 1F ). On average, dMSNs in control animals displayed larger EPSC amplitudes than iMSNs (dMSN, 408.2 ± 86.0; iMSN, 311.1 ± 58.7 pA; n = 10; Figure 1G ), and the average pairwise ratio revealed stronger dMSN synaptic drive (d:i ratio, 1.5 ± 0.3; Figure 1H ). However, 1 to 2 weeks following 6OHDA-mediated ablation of striatal dopamine, EPSC amplitudes in iMSNs were significantly larger than those in dMSNs (dMSN, 180.0 ± 36.2; iMSN, 406.8 ± 80.9 pA; n = 16; Figure 1G) , and the average pairwise ratio revealed a shift to preferential iMSN synaptic drive (d:i ratio, 0.70 ± 0.2; p = 0.016 versus control; Figure 1H ).
No Relative Change in Corticostriatal Synaptic Strength in Parkinsonian Animals
ChR2-EYFP injections into Emx1-Cre animals resulted in extensive labeling of sensorimotor cortical neurons across layers ( Figure 2A ) and intense axonal labeling in the DLS ( Figure 2B ). As with thalamostriatal recordings, brief illumination ( Figure 2E ) elicited short-latency EPSCs in both MSN subtypes ( Figure 2F ). Paired recordings revealed larger EPSCs in dMSNs than iMSNs in control animals (dMSN, 403.6 ± 40.9; iMSN, 323.7 ± 45.2 pA; d:i ratio, 1.5 ± 0.2; n = 16; Figures 2G and 2H ), as seen with our thalamostriatal stimulation and in previous investigations of relative cortical drive to d/iMSN pairs (Kress et al., 2013) . Recordings from 6OHDA-lesioned animals revealed no significant change in the relative corticostriatal drive to dMSNs and iMSNs compared to control animals (dMSN, 316.3 ± 43.3; iMSN, 240.8 ± 23 .1 pA; d:i ratio, 1.4 ± 0.2; n = 12; p = 0.741 versus control; Figures 2G and 2H ).
Postsynaptic Decrease in AMPAR-Mediated Responses at Thalamo-dMSN Synapses
The PD-associated reorganization of thalamostriatal excitatory drive might reflect changes in presynaptic glutamate release, which should be reflected in paired pulse ratio (PPR) measurements. By experimentally manipulating the external calcium concentration, we confirmed the sensitivity of optogenetically evoked PPR measurements to changes in presynaptic release probability ( Figure S1 ). After dopamine depletion, the d:iMSN PPR was unchanged at both corticostriatal (control versus 6OHDA; 1.0 ± 0.1 versus 1.0 ± 0.1, p = 0.899; n = 16 versus 12) and thalamostriatal (1.1 ± 0.1 versus 1.0 ± 0.1, p = 0.755; n = 10 versus 16) synapses ( Figures 3A-3C ), suggesting no change in presynaptic release probability at thalamostriatal or corticostriatal synapses in parkinsonian animals. Furthermore, while studies in humans and other PD models have reported significant cell loss within CM/Pf, we saw no difference in the density of Pf cells between control and 6OHDA animals ( Figure S2 ).
To test whether remodeling of thalamostriatal excitatory drive in parkinsonian animals was associated with alterations in postsynaptic function, we measured AMPA-and NMDA-EPSCs ( Figure 3D ). Thalamostriatal inputs showed a specific reduction in d:iMSN AMPA ratio, but not in d:iMSN NMDA ratio (control versus 6OHDA; d:i AMPA, 1.2 ± 0.2 versus 0.7 ± 0.1, p = 0.026; d:i NMDA, 1.1 ± 0.2 versus 1.2 ± 0.3, p = 0.628; n = 18 versus 15; Figure 3E ). In theory, the decreased thalamostriatal d:iMSN AMPA ratio in parkinsonian mice could arise from a postsynaptic decrease in dMSN and/or an increase in iMSN EPSC amplitude. However, the AMPA:NMDA ratio was selectively decreased at thalamo-dMSN, but not thalamo-iMSN, synapses (control versus 6OHDA AMPA:NMDA; dMSN, 4.3 ± 0.7 versus 2.2 ± 0.3, n = 18 versus 16, p = 0.015; iMSN, 4.3 ± 0.8 versus 3.5 ± 0.5, n = 19 versus 16, p = 0.389; Figure 3F ), indicating a decrease in dMSN EPSC amplitude. Cortico-dMSN synapses showed a slight increase in AMPA:NMDA ratio (control versus 6OHDA AMPA:NMDA; dMSN, 3.3 ± 0.3 versus 4.5 ± 0.5, n = 16 versus 13, p = 0.028; iMSN, 3.4 ± 0.5 versus 3.8 ± 0.4, n = 12 versus 12, p = 0.568; Figure 3F ) but no significant change in d:iMSN AMPA and NMDA currents (control versus 6OHDA; d:i AMPA, 1.4 ± 0.2 versus 1.6 ± 0.2, p = 0.365; d:i NMDA, 1.3 ± 0.1 versus 1.3 ± 0.2, p = 0.900; n = 10 versus 10; Figure 3E ).
Based on the specific decrease in thalamo-dMSN EPSCs after dopamine depletion, we next tested whether postsynaptic longterm depression (LTD) at this synapse is occluded in parkinsonian animals. 5 min of 1 Hz thalamostriatal stimulation paired with postsynaptic dMSN depolarization to À40 mV produced a significant decrease in both EPSC amplitude and AMPA:NMDA ratio in control mice. However, no change in EPSC amplitude or AMPA:NMDA ratio was observed in parkinsonian mice (Figures 3G and 3H) (EPSC control versus 6OHDA percent of baseline, 0.82 ± 0.07 versus 1.00 ± 0.09, p = 0.04 versus 0.48, n = 6 versus 11; AMPA:NMDA control versus 6OHDA percent of baseline, 0.79 ± 0.09 versus 0.97 ± 0.05, p = 0.03 versus 0.28; baseline 6OHDA AMPA:NMDA as percent of control baseline, 0.53 ± 0.08, p = 0.02). Given that baseline AMPA:NMDA ratios were already significantly lower in parkinsonian mice versus controls ( Figure 3F ), our data are consistent with the hypothesis that dopamine depletion induces an LTD-like loss of AMPA receptors at thalamo-dMSN synapses.
Inhibition of Thalamostriatal Inputs Rescues Parkinsonian Motor Behavior
Given the reported increase in firing of thalamic CM/Pf neurons in PD models (Jouve et al., 2010; Magnin et al., 2000; Orieux et al., 2000; Parr-Brownlie et al., 2009; Yan et al., 2008) , and the decrease in thalamic connectivity with dMSNs after chronic dopamine depletion, we hypothesized that thalamostriatal inputs might be actively contributing to decreased spontaneous motor activity in parkinsonian mice through selective drive of the indirect pathway, relative to the direct pathway. We reasoned that disconnection of this pathway could rescue motor behavior. To test this hypothesis, we expressed hM4D, a Gi-coupled receptor activated exclusively by clozapine N-oxide (CNO) (Ferguson et al., 2011) , in intralaminar thalamic neurons and implanted bilateral cannulae in DLS for local infusion of saline or CNO at thalamostriatal synapses ( Figures 4A and S4) . The same animals received bilateral intra-DLS injections of saline or 6OHDA to produce bilateral, DLS-specific lesions of dopaminergic axons. In mice co-injected with ChR2 virus, optogenetically evoked EPSCs in both dMSNs and iMSNs were strongly suppressed by bath application of CNO (baseline, 308.1 ± 97.0; CNO, 141.8 ± 65.7 pA; p = 0.025; n = 6; Figure S3 ), confirming hM4D-mediated suppression of glutamate release. Intra-DLS infusion and intraperitoneal (i.p.) injection of CNO into parkinsonian mice significantly increased the amount of time spent ambulating (saline versus CNO: DLS, 33.8% ± 4.7% versus 44.9% ± 6.5%, p = 0.039, n = 6; i.p., 37.3% ± 5.0% versus 56.1% ± 5.2%, p = 0.003; n = 16), and i.p. injection decreased the amount of time spent freezing (DLS, 12.2% ± 4.8% versus 7.1% ± 3.2%, p = 0.058; i.p., 19.8% ± 4.5% versus 8.3% ± 2.1%, p = 0.012) relative to saline infusion/injection ( Figure 4C) . DLS infusion and i.p. injection of CNO also increased average center-point velocity (saline versus CNO: DLS, 1.86 ± 0.23 versus 2.59 ± 0.32 cm/s, p = 0.028; i.p., 2.0 ± 0.3 versus 3.4 ± 0.5 cm/s, p = 0.009; Figure 4D ). Activation of thalamic hM4D receptors in control animals had no effect on spontaneous motor behavior (saline versus CNO: DLS, ambulation 37.1% ± 3.4% versus 36.7% ± 4.2% p = 0.47, freezing 5.9% ± 1.4% versus 4.7% ± 1.5% p = 0.22, velocity 2.0 ± 0.16 versus 2.05 ± 0.21 cm/s, p = 0.43 n = 8; i.p., ambulation 52.7% ± 3.5% versus 53.5% ± 3.2% p = 0.888, freezing 4.1% ± 1.0% versus 4.3% ± 1.4% p = 0.917, velocity 2.7 ± 0.2 versus 2.8 ± 0.2 cm/s p = 0.660, n = 17; Figures 4C and 4D) .
To test whether this amelioration of parkinsonian state is acute and reversible, we expressed the inhibitory light-gated proton pump eArch3.0 (Mattis et al., 2012) in intralaminar thalamic neurons and implanted bilateral optical fibers in DLS of animals injected bilaterally with saline or 6OHDA in DLS ( Figures 4E and S4 ). eArch3.0-mediated inactivation (10-15 mW/mm 2 , 532 nm, 30 s) of thalamostriatal terminals in parkinsonian animals rapidly and reversibly increased ambulation (pre 11.5% ± 3.6%, laser 19.6% ± 6.0%, post 11.7% ± 3.5%, p = 0.022, n = 6) decreased freezing (pre 33.5% ± 7.5%, laser 22.6% ± 6.0%, post 29.8% ± 5.5%, p = 0.009), and No changes were seen with eArch3.0-mediated inhibition of thalamostriatal terminals in control animals (ambulation, pre 19.7% ± 4.1%, laser 18.7% ± 3.8%, post 18.2% ± 3.2%, p = 0.306; freezing, pre 20.7% ± 7.7%, laser 21.5% ± 8.6%, post 19.5% ± 7.4%, p = 0.366; velocity, pre 1.08 ± 0.18, laser 1.03 ± 0.18, post 1.02 ± 0.15 cm/s, p = 0.227, n = 9; Figures 4G and 4H), consistent with a detrimental gain-of-function of thalamostriatal inputs in parkinsonian animals.
DISCUSSION
Historically, cortical and thalamic terminals have been differentiated by their expression of VGLUT1 and VGLUT2, respectively (Fremeau et al., 2001; Fujiyama et al., 2001; Herzog et al., 2001 ). Recent evidence suggests there is a selective loss of striatal VGLUT2+ terminals in monkey MPTP models (R.M. Villalba et al., 2013, Soc. Neurosci., abstract). Our data indicate that reduced thalamostriatal synaptic input is specific to dMSNs in parkinsonian animals. Although our study did not selectively target Pf, other work has found distinct synaptic properties at Pf versus central lateral thalamic inputs (Ellender et al., 2013) , indicating that it will be critical to learn whether changes to thalamostriatal inputs in parkinsonian animals apply only to specific intralaminar nuclei or more broadly. Neurons in the intralaminar thalamus have been previously implicated in PD. CM/Pf neurons in PD patients and animal models show higher firing rates and increased oscillatory activity (Jouve et al., 2010; Orieux et al., 2000; Parr-Brownlie et al., 2009; Yan et al., 2008) . In parkinsonian rats, Pf lesions decrease response latency on a motivational task (Henderson et al., 2005) , and Pf DBS rescues sensorimotor neglect (Jouve et al., 2010) . In PD patients, Pf DBS effectively reduces tremor and, as seen in rodent models, reduces levodopa-induced dyskinesia (Caparros-Lefebvre et al., 1999; Mazzone et al., 2006; Peppe et al., 2008; Stefani et al., 2009) . These studies, together with our data, support the notion that a parkinsonian gain-of-function of intralaminar thalamus contributes to basal ganglia pathophysiology in PD (Chen et al., 2014) . Indeed, CM/Pf inactivation using hM4D or eArch3.0 showed no effect in control animals, consistent with previous studies that found no effect of CM/Pf lesion on spontaneous motor behavior (Henderson et al., 2005; Quiroz-Padilla et al., 2006) . Thus, the normal role of CM/Pf may be in sensory-driven rather than internally driven behavior (Matsumoto et al., 2001; Minamimoto et al., 2005) .
The lack of change in the relative d/iMSN cortical synaptic drive in our study is quite surprising given the rich literature surrounding corticostriatal synaptic reorganization in PD; for example, the loss of VGLUT1-associated spines in parkinsonian mice and their aberrant restoration in L-DOPA-induced dyskinesia (Zhang et al., 2013) . However, even with significant alterations to dMSN and iMSN morphology and physiology, broad activation of Thy1-ChR2 afferents in striatum reveals minor changes in overall EPSC amplitudes (Fieblinger et al., 2014) . Our data suggest that, despite the many changes seen to the presumptive corticostriatal anatomy in PD models, the ultimate outcome of these changes is the maintenance of relative drive to the direct and indirect pathways.
Significant CM/Pf cell loss occurs in PD patients and monkey MPTP models. However, we did not see evidence for Pf cell death in our 6-OHDA model. It is therefore difficult to predict whether the changes seen here are recapitulated in patients and primate models. Future studies should investigate this issue, as the pathway-specific reorganization seen here would deleteriously add to the known thalamostriatal changes in PD discussed above. Overall, our results highlight the need for a better understanding of the molecular mechanisms behind thalamostriatal plasticity in normal and disease states and closer consideration of the thalamus as a major player in the pathophysiology of Parkinson's disease.
EXPERIMENTAL PROCEDURES
All experiments were approved by the Institutional Animal Care and Use Committee at the University of California, San Francisco.
Surgeries 6-to 10-week-old mice were anesthetized and placed in a stereotaxic frame, and a 33G needle (Plastics One) was inserted for viral injections into cortex (AP +0.5/1.5, ML ± 2.0, DV À1.0 from dura) or thalamus (AP À2.3, ML ± 0.5, DV À3.25 from dura). A volume of 0.75 ml/site of virus was injected at a rate of 0.2 ml/min. 2 weeks later, the scalp was reopened and 1 ml of 5 mg/ml 6-hydroxydopamine (6OHDA; Sigma-Aldrich) was injected unilaterally into the medial forebrain bundle (MFB; AP À1.0, ML À1.0, DV À4.9 from dura) or bilaterally into the DLS (AP +0.8, ML ± 2.2, DV À2.5 from dura). Electrophysiology 1 to 2 weeks after 6-OHDA/saline injection, acute slices (300 mm) were cut through the DLS in sucrose-based artificial cerebrospinal fluid (ACSF). Simultaneous voltage-clamp recordings were made from one D1-Tomato+ and one D1-TomatoÀ MSN using 2-4 MU glass electrodes. Light pulses (470 nm, 0-2 mW/mm 2 , 0.5-5 ms duration) were delivered through a 403 immersion objective at 0.05 Hz using a high-intensity LED (Thorlabs LED4C driven by a Prizmatix BLCC-2).
Open Field Behavior 1 to 2 weeks after 6-OHDA/saline injection, activity in the open field was tracked using ETHOVISION 9 software (Noldus). Statistical significance was evaluated using a two-way ANOVA and post hoc Bonferroni-corrected paired Student's t test. Animals were excluded if incomplete bilateral loss of TH+ axonal labeling in DLS was achieved (6OHDA group), quantified as <30% loss of total striatal TH staining, or if the location of the cannula/fiber tip was outside of DLS (both groups).
Histology
Mice were transcardially perfused with PBS followed by 4% paraformaldehyde (PFA); brains were rapidly dissected out and placed into 4% PFA overnight. Brains were rinsed in PBS, cryoprotected, and sliced (30 mm). After blocking and permeabilization, slices were incubated in primary antibody (rabbit anti-tyrosine hydroxylase 1:500, Pel-Freeze; mouse anti-RFP 1:500, Rockland Immunochemicals; rabbit anti-cerebellin1, 1:250, Abcam) overnight at 4 C. Slices were then incubated in secondary antibody (donkey anti-mouse Alexa568, donkey anti-rabbit Alexa647, 1:1,000, Invitrogen) for 1 hr at room temperature and mounted onto slides for imaging.
SUPPLEMENTAL INFORMATION
Supplemental Information includes four figures and Supplemental Experimental Procedures and can be found with this article online at http://dx.doi. org/10.1016/j.neuron.2015.12.038.
AUTHOR CONTRIBUTIONS
P.R.L.P. designed and performed experiments, analyzed data, and wrote the manuscript. A.L.L. designed and performed behavior experiments. A.C.K. designed experiments, wrote the manuscript, and supervised the research.
